Common Contracts

PDL BIOPHARMA, INC. as Issuer AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee SUPPLEMENTAL INDENTURE Dated as of February 12, 2014 4.00% Convertible Senior Notes due 2018

Supplemental Indenture • February 12th, 2014 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Supplemental Indenture
• Filed
  February 12th, 2014
• Company
  PDL Biopharma, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

SUPPLEMENTAL INDENTURE, dated as of February 12, 2014 (this “Supplemental Indenture”), between PDL BioPharma, Inc., a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A, as trustee (the “Trustee”) under the Indenture dated as of February 12, 2014, between the Company and the Trustee (as amended or supplemented from time to time in accordance with the terms thereof, the “Original Indenture”).

PDL BIOPHARMA, INC. as Issuer AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. as Trustee SUPPLEMENTAL INDENTURE Dated as of May 16, 2011 3.75% Convertible Senior Notes due 2015

Supplemental Indenture • May 16th, 2011 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Supplemental Indenture
• Filed
  May 16th, 2011
• Company
  PDL Biopharma, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

SUPPLEMENTAL INDENTURE, dated as of May 16, 2011, between PDL BioPharma, Inc., a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A, as trustee (the “Trustee”) under the Indenture dated as of May 16, 2011, between the Company and the Trustee (as amended or supplemented from time to time in accordance with the terms thereof, the “Original Indenture”).